Oct 6 (Reuters) - Goldman Sachs Group Inc ( GS ):

* MAPLIGHT THERAPEUTICS INC - INITIAL PUBLIC OFFERING PRICE

IS

$17.00 PER SHARE

* MAPLIGHT THERAPEUTICS INC SEES IPO OF 14.75 MILLION SHARES

OF

COMMON STOCK - SEC FILING

* MAPLIGHT THERAPEUTICS - AFFILIATES OF GOLDMAN SACHS & CO.

LLC

ARE EXPECTED TO PURCHASE 476,707 SHARES OF COMMON STOCK IN

CONCURRENT PRIVATE PLACEMENT

* MAPLIGHT THERAPEUTICS - ACCOUNTS ADVISED BY T. ROWE PRICE

INVESTMENT MANAGEMENT INDICATED INTEREST IN PURCHASING UP TO $40

MILLION IN SHARES AT IPO PRICE

Source text:

Further company coverage: